QP & Analytical Services

Our qualified scientists and experienced Qualified Persons are assigned to your project from the very first discussion. This ensures the project scope is fully mapped and a comprehensive risk assessment performed.

QP Supply Chain Declaration for Investigational Medicinal Product (IMP) from Outside the European Union.

Piramal Clinical Trial Services is in a unique position to offer as the point of Import and EU release of your IMP for use in European Clinical Trials.

If the manufacturing and/or testing site is outside the EU or EEA then a QP named on the manufacturing authorisation that authorises the importation, will be required to certify that the manufacturing and testing site operates in accordance with standards equivalent to EU cGMP. The QP will be required to submit a supply chain declaration as part of the Clinical Trial Application.

Overseas site visits and audits will be necessary if there are in the QP's opinion, outstanding information or more detailed scrutiny of the sites quality systems. In such circumstances Piramal has available an in-country EU registered QP to support the GMP audits thereby reducing the cost and audit time-lines. Read more: